Biolargo (BLGO) Operating Expenses (2010 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Biolargo was $19.76 million, up 55.3% year-over-year; for FY2025, it was $18.26 million, up 49.9% from FY2024.

• Annual Operating Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
• In prior years, Biolargo's Operating Expenses was $12.18 million in FY2024 (+13.5%), $10.73 million in FY2023 (+30.2%), $8.25 million in FY2022 (+4.6%) and $7.88 million in FY2021 (-10.6%).
• Quarterly Operating Expenses has run from a low of $1.7 million in Q3 2022 to a high of $7.55 million in Q3 2025 over five years.
• On a year-over-year basis, Operating Expenses has increased in each of the last seven quarters, with growth averaging 32.6% over the last eight quarters.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q3 2025, with growth of 171.4%; the weakest was Q3 2021, with a decline of 20.6%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $3.66 million (Q1 2026), $4.14 million (Q4 2025) and $7.55 million (Q3 2025).